Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-19
1994-10-18
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514333, 514412, 514414, 514415, 514419, A61K 3144, A61K 3140, A61K 31405
Patent
active
053569105
ABSTRACT:
There is disclosed a method of alleviating obsessive compulsive disorders which comprises administration of an effective amount of a compound of the formula. ##STR1## where m is 1 or 2;
REFERENCES:
patent: 4880822 (1989-11-01), Effland et al.
patent: 4970218 (1990-11-01), Effland et al.
patent: 5179099 (1993-01-01), Effland et al.
Kongsamut Sathapana
Smith Craig P.
Woods Ann T.
Cintins Marianne M.
Hoechst-Roussel Pharmaceuticals Inc.
Ikeda Tatsuya
Weddington K.
LandOfFree
Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obse does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obse, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obse will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2372732